Studies available for: Prostate Cancer

See a study that interests you? Contact that study's coordinator for more information on how to participate.


Study Information:
Clinical Study to Evaluate the Ability of Muse to Decrease Erectile Function Recovery Time in Post Radical Prostatectomy Patients Study RP-01
Houston, Tx
The University of Texas Health Science Center - Division of Urology
The objectives of this study are to 1) determine if early introduction of MUSE (study drug)after nerve-sparing radical prostatectomy (RP) reduces the time required for spontaneous erections and 2) determine if early introduction of MUSE after nerve sparing RP reduces the time required for the return of Viagra induced erectile function when administered on an as-needed basis. This is an 11 month study with 8 visits.
HSC-MS-05-0425
VIVUS, INC.
Subject Information:
adult males less than 70 years old
Inclusion: Be adult male less than 70yrs of age have normal erectile function, defined by presurgery score on the IIEF have undergone a bilateral nerve-sparing radical prostatectomy for prostate cancer have postsurgery ED be willing and able to self-administer MUSE or VIagra nightly for 9months or until there is evidence of spontaneous erectile function be in stable, monogamous, hetrosexual relationship provide written informed consent (both subject and partner) be willing and able to comply with all study requirements, visit schedules and procedures Exclusion: have preoperative ED as determined by an IIEF domain score less than 26 have a history of T3 or T4 disease have a tumor Gleason score equal to or grea
Study Coordinator(s) Information:
Comalita Lee
comalita.lee@uth.tmc.edu
713-500-6086
Franchelle Bourgeois
franchelle.bourgeois@uth.tmc.edu
713-500-7324
Principal Investigator Information:
Dr. Run Wang